Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

por Lederhofer, J., van Lent, J., Bhoelan, F., Karneva, Z., de Haan, A., Wilschut, J.C., Stegmann, T.
Publicado 2018

Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination

por Assink, M.D.M., Kiewiet, J.P., Rozenbaum, M.H., Van den Berg, P.B., Hak, E., Buskens, E.J., Wilschut, J.C., Kroes, A.C.M., Postma, M.J.
Publicado 2009